Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats: Evidence for a role of endothelin in vascular hypertrophy

Hypertension

Volumn 24, Issue 2, 1994, Pages 183-188

  Li, Jin S ^a   Larivière, Richard ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

blood pressure; endothelium; hypertension, mineralocorticoid; hypertrophy; receptors, endothelin; resistance arteries

Indexed keywords

BOSENTAN; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY MEDIA; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM; HYPERTENSION; HYPERTROPHY; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; VASCULARIZATION; VASOCONSTRICTION;

EID: 0027959070     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.24.2.183     Document Type: Article

References (31)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T. The human endothelin family: 3 structurally and pharmacologically distinct isopeptides predicted by 3 separate genes. Proc Nail Acad Sci U S A. 1989;86:2863-2867.
3. Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis. 1989; 78:225-228.
4. Suzuki N, Miyauchi T, Tomobe Y, Matsumoto H, Goto K, Masaki T, Fujino M. Plasma concentrations of endothelin-1 in spontaneously hypertensive rats and DOCA-salt hypertensive rats. Biochem Biophys Res Commun. 1990;167:941-947.
5. Kohno M, Yasumari K, Murakawa K, Yokokawa K, Horio T, Fukui T, Takeda T. Plasma immunoreactive endothelin in essential hypertension. Am J Med. 1990;88:614-618.
6. Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, Dickerson C, Nunez DJ, Capper SJ, Brown MJ. A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci. 1990:78: 261-264.
7. Schiffrin EL, Thibault G. Plasma endothelin in human essential hypertension. Am J Hypertens. 1991;4:303-308.
8. Clozel M. Endothelin sensitivity and receptor binding in the aorta of spontaneously hypertensive rats. J Hypertens. 1989;7:913-917.
9. Nguyen PV, Yang X-P, Li G, Deng LY, Flückiger J-P, Schiffrin EL. Contractile responses and signal transduction of endothelin-1 in aorta and mesenteric vasculature of adult spontaneously hypertensive rats. Can J Physiol Pharmacol. 1993;71:473-483.
10. Nguyen PV, Parent A, Deng LY, Flückiger JP, Thibault G, Schiffrin EL. Endothelin vascular receptors and responses in DOCA-salt hypertensive rats. Hypertension. 1992;19(suppl II):II-98-II-104.
11. Deng LY, Schiffrin EL. Effects of endothelin-1 and vasopressin on resistance arteries of spontaneously hypertensive rats. Am J Hypertens. 1992;5:817-822.
12. Dohi Y, Luscher TF. Endothelin in hypertensive resistance arteries: intraluminal and extraluminal dysfunction. Hypertension. 1991;18:543-549.
13. Deng LY, Schiffrin EL. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats. Am J Physiol. 1992;262:H1782-H1787.
14. Schiffrin EL, Deng LY, Larochelle P. Blunted effects of endothelin on small subcutaneous resistance arteries of mild essential hypertensive patients. J Hypertens. 1992;10:437-444.
15. Larivière R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension. 1993;21:294-300.
16. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, Binder BR. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem. 1992;267: 16066-16068.
17. Larivière R, Day R, Schiffrin EL. Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetatesalt hypertensive rats. Hypertension. 1993;21:916-920.
18. A) receptor antagonist in conscious rats. J Cardiovasc Pharmacol. 1992;20:940-948.
19. B receptors on aortic smooth muscle cells of spontaneously hypertensive rats. Am J Physiol. 1993;264:C479-C484.
20. B receptors. FEBS Lett. 1993;334:210-214.
21. Clozel M, Breu V, Burri K, Cassai J-M, Fischli W, Gray GA, Hirth G, Löffler B-M, Müller M, Neidhart W, Ramuz H. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 1993;365:759-761.
22. Clozel M, Breu V, Gray GA, Kalina B, Löffler B-M, Burri K, Cassal J-M, Hirth G, Muller M, Neidhart W, Ramuz H. Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J Pharmacol Exp Ther. In press.
23. Ormsbee HS, Ryan CF. Production of hypertension with deoxycorticosterone acetate-impregnated silicone rubber implants. J Pharmacol Sci. 1973;62:255-257.
24. Löffler B-M, Breu V, Clozel M. Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma. FEBS Lett. 1993;333: 108-110.
25. Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S. Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol. 1990;258:C408-C415.
26. Chua BHL, Krebs CJ, Chua CC, Diglio CA. Endothelin stimulates protein synthesis in smooth muscle cells. Am J Physiol. 1992;262: E412-E416.
27. Deng LY, Schiffrin EL. Effect of antihypertensive treatment on response to endothelin of resistance arteries of hypertensive rats. J Cardiovasc Pharmacol. 1993;21:725-731.
28. Lockette W, Otsuka Y, Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension. 1986; 8(suppl II);II-61-II-66.
29. Stacy LD, Scott JW, Granger JP. Control of renal function during intrarenal infusion of endothelin. Am J Physiol. 1990;258: F1232-F1236.
30. B receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney. Br J Pharmacol. 1994;111:515-520.
31. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao W-H, Kamada N et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature. 1994;368:703-710.